NASDAQ:ENTO Stock Quote
0.4804
-0.0546 (-10.21%)
Entero Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for gastrointestinal disorders and related health conditions
The company is dedicated to advancing its proprietary drug delivery technologies and treatment strategies that target the gastrointestinal tract, aiming to improve the lives of patients with challenging medical issues. Through rigorous research and development, Entero is committed to addressing unmet medical needs in the field of digestive health and enhancing the effectiveness of existing therapies.